In September 2025, the FDA issued over 50 warning letters to companies marketing compounded GLP-1 products with misleading claims
The logic behind three times weekly dosing relates to semaglutide half-life
Renowned for its capacity to control hunger and enhance metabolic wellness, Semaglutide GLP-1 has become a popular choice for individuals striving to attain and sustain an optimal weight
Under federal law, compounding can be appropriate when a patient requires a different dosage or formulation from what is commercially available
Ophthalmol Sci 2024;4:100547.ArticlePubMedPMC 95
In addition, in the vast majority of these studies, liraglutide was used at low or medium doses, while it is well known that some effects, in particular weight loss, are dose-dependent and more pronounced at the maximum dose